Ono Pharmaceutical Co., Ltd.

OTCPK:OPHL.Y Stock Report

Market Cap: US$5.2b

Ono Pharmaceutical Future Growth

Future criteria checks 0/6

Ono Pharmaceutical's earnings are forecast to decline at 5.8% per annum while its annual revenue is expected to grow at 1.3% per year. EPS is expected to decline by 5.8% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

-5.8%

Earnings growth rate

-5.8%

EPS growth rate

Pharmaceuticals earnings growth23.9%
Revenue growth rate1.3%
Future return on equity7.7%
Analyst coverage

Good

Last updated19 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:OPHL.Y - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027524,83377,66879,909111,94512
3/31/2026515,89673,69466,54698,93513
3/31/2025484,25763,817-43,83141,6459
9/30/2024484,29895,12791,943108,662N/A
6/30/2024500,331120,953105,249121,111N/A
3/31/2024502,672127,97789,831110,660N/A
12/31/2023498,070127,61191,301106,044N/A
9/30/2023489,199124,87597,371115,354N/A
6/30/2023460,481115,06498,429116,894N/A
3/31/2023447,187112,723145,113159,610N/A
12/31/2022428,951111,555137,391149,495N/A
9/30/2022403,98596,56893,387102,437N/A
6/30/2022380,72085,92278,39588,151N/A
3/31/2022361,36180,51949,55261,829N/A
12/31/2021345,78173,55838,23353,343N/A
9/30/2021332,88781,86660,41283,032N/A
6/30/2021321,73478,00347,40170,321N/A
3/31/2021309,28475,42553,68473,977N/A
12/31/2020302,05474,36453,08872,011N/A
9/30/2020293,88666,73755,74270,596N/A
6/30/2020293,35164,87058,82478,232N/A
3/31/2020292,42059,70451,71274,157N/A
12/31/2019290,73660,23343,20273,947N/A
9/30/2019293,24755,51038,79766,058N/A
6/30/2019291,37452,63332,15258,850N/A
3/31/2019288,63451,53937,17266,774N/A
12/31/2018284,46351,97842,50067,269N/A
9/30/2018284,78557,91929,64561,700N/A
6/30/2018272,16553,746N/A48,716N/A
3/31/2018261,83650,284N/A15,727N/A
12/31/2017256,52254,760N/A28,754N/A
9/30/2017248,51753,884N/A40,205N/A
6/30/2017246,95353,887N/A53,650N/A
3/31/2017244,79755,793N/A74,450N/A
12/31/2016236,71048,270N/A44,743N/A
9/30/2016207,70736,225N/A32,972N/A
6/30/2016183,34529,206N/A16,805N/A
3/31/2016160,28424,979N/A12,842N/A
12/31/2015140,92716,449N/A29,716N/A
9/30/2015143,69721,568N/A31,169N/A
6/30/2015139,66319,521N/A30,488N/A
3/31/2015135,77512,976N/A31,579N/A
12/31/2014137,59217,663N/AN/AN/A
9/30/2014133,92613,474N/A19,681N/A
6/30/2014137,14616,787N/AN/AN/A
3/31/2014143,24720,350N/A28,422N/A
12/31/2013145,94621,574N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OPHL.Y's earnings are forecast to decline over the next 3 years (-5.8% per year).

Earnings vs Market: OPHL.Y's earnings are forecast to decline over the next 3 years (-5.8% per year).

High Growth Earnings: OPHL.Y's earnings are forecast to decline over the next 3 years.

Revenue vs Market: OPHL.Y's revenue (1.3% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: OPHL.Y's revenue (1.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: OPHL.Y's Return on Equity is forecast to be low in 3 years time (7.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y